Chris Teleha

Title: Chris Teleha: Innovator in Ligand-Mediated Ullmann Coupling

Introduction

Chris Teleha is a notable inventor based in Bear, Delaware, who has made significant contributions to the field of chemistry. His innovative work focuses on the development of methods that enhance chemical reactions, particularly in the synthesis of pharmaceutical compounds.

Latest Patents

Chris Teleha holds a patent for an invention titled "Efficient ligand-mediated Ullmann coupling of anilines and azoles." This patent describes a method for preparing phenyl-substituted azoles through an efficient ligand-accelerated Ullmann coupling reaction of anilines with azoles. The coupling products generated from this method are particularly useful for the preparation of factor Xa inhibitors, which are important in the treatment of various medical conditions.

Career Highlights

Chris Teleha is currently employed at Bristol-Myers Squibb Pharma Company, where he continues to apply his expertise in chemical synthesis and innovation. His work at this leading pharmaceutical company allows him to contribute to the development of new therapeutic agents that can improve patient outcomes.

Collaborations

Throughout his career, Chris has collaborated with talented colleagues, including Jiacheng Zhou and Pasquale N. Confalone. These collaborations have fostered a productive environment for innovation and have led to advancements in their respective fields.

Conclusion

Chris Teleha's contributions to the field of chemistry, particularly through his patent on ligand-mediated Ullmann coupling, highlight his role as an innovator in pharmaceutical development. His work continues to impact the industry positively, paving the way for new therapeutic solutions.